Lifestyle interventions for acute gout

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 11, 2013, Pages

  Moi, John H Y ^a   Sriranganathan, Melonie K ^b   Edwards, Christopher J ^b   Buchbinder, Rachelle ^c  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CAFFEINE; COLCHICINE; GLUCOCORTICOID; INTERLEUKIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PREDNISOLONE; PURINE; ANTIGOUT AGENT; ANTIINFLAMMATORY AGENT;

ARTHRALGIA; COMBINATION DRUG THERAPY; COMPARATIVE EFFECTIVENESS; CONSERVATIVE TREATMENT; DIETARY INTAKE; FOOD INTAKE; GOUT; HUMAN; INTERVENTION STUDY; JOINT FUNCTION; JOINT SWELLING; LIFESTYLE MODIFICATION; OUTCOME ASSESSMENT; PLACEBO EFFECT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REST; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SENSITIVITY ANALYSIS; SMOKING CESSATION; SWEETENED BEVERAGE; SYSTEMATIC REVIEW; TOPICAL ANESTHESIA; TOPICAL ICE THERAPY; VISUAL ANALOG SCALE; ACUTE DISEASE; CRYOTHERAPY; DRUG COMBINATION; LIFESTYLE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; ARTICLE; CLINICAL EFFECTIVENESS; PATIENT SAFETY;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS; COLCHICINE; COMBINED MODALITY THERAPY; CRYOTHERAPY; DRUG THERAPY, COMBINATION; GOUT; GOUT SUPPRESSANTS; HUMANS; LIFE STYLE; PREDNISOLONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84900757732     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010519.pub2     Document Type: Review

References (45)

1. Schlesinger N, Detry MA, Holland BK, Baker DG, Beutler AM, Rull M, et al. Local ice therapy during bouts of acute gouty arthritis. Journal of Rheumatology 2002;29:331-4.
2. Zeng YC, Huang SF, Mu GP, Wang TF. Effects of adjusted proportional macronutrient intake on serum uric acid, blood lipids, renal function and outcome of patients with gout and overweight [zhong guo lin chuang ying yang za zhi]. Chinese Journal of Clinical Nutrition 2012;20(4):210-4.
3. Zhao QW, Liu J, Qu XD, Li W, Wang S, Gao Y, Zhu LW. Observation on therapeutic effect of electroacupuncture plus blood-letting puncture and cupping combined with diet intervention for treatment of acute gouty arthritis. Zhongguo zhen jiu [Chinese Acupuncture & Moxibustion] 2009;29(9):711-3.
4. Axelrod D, Preston S. Comparison of parenteral adrenocorticotrophic hormone with oral indomethacin in the treatment of acute gout. Arthritis and Rheumatism 1988;31(6):803-5.
5. Boutron I, Moher D, Altman DG, Schulz K, Ravaud P, for the CONSORT group. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Annals of Internal Medicine 2008;148:295-309.
6. Dr Christopher Cates. Dr Chris Cates' EBM website, Visual Rx. 3. Dr Christopher Cates, 2008.
7. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. New England Journal of Medicine 2004;350:1093-103.
8. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004;363:1277-81.
9. Choi HK, Curhan G. Beer, liquor, wine, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis and Rheumatism 2004;51:1023-9.
10. Choi KY, Mount DB, Reginato AM. Pathogenesis of gout. Annals of Internal Medicine 2005;143(7):499-516.
11. Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Archives of Internal Medicine 2005;165:742-8.
12. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, dairy products, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis and Rheumatism 2005;52:283-9.
13. Choi HK, Willett W, Curhan G. Coffee consumption and risk of incident gout in men. Arthritis and Rheumatism 2007;56(6):2049-55.
14. Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome inpatients with gout: the Third National Health and Nutrition Examination Survey. Arthritis and Rheumatism 2007;57:109-115.
15. Choi HK, Curhan G. Coffee, tea, and caffeine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis and Rheumatism 2007;57:816-21.
16. Choi HK, Willett W, Curhan G. Fructose-rich beverages and risk of gout in women. JAMA 2010;304(20):2270-8.
17. Choi HK. A prescription for lifestyle change in patients with hyperuricemia and gout. Current Opinion in Rheumatology 2010;22:165-72.
18. Dalbeth N, Wong S, Gamble GD, Horne A, Mason B, Pool B, et al. Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial. Annals of the Rheumatic Diseases 2010;69:1677-82.
19. Dalbeth N, Ames R, Gamble GD, Horne A, Wong S, Kunh-Sherlock B, et al. Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extracton on frequency of gout flares: a proof-of-concept randomised controlled trial. Annals of the Rheumatic Diseases 2012;71(6):929-34.
20. DeAngelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 2004;292:1363-4.
21. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
22. Giamarellos-Bourboulis EJ, Mouktaroudi M, Bodar E, van der Ven J, Kullberg B-J, Netea MG, et al. Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process. Annals of the Rheumatic Diseases 2009;68(2):273-8.
23. Grainger R, Taylor WJ, Dalbeth N, Perez-Ruiz F, Singh JA, Waltrip RW, et al. Progress in measurement instruments for acute and chronic gout studies. Journal of Rheumatology 2009;36(10):2346-55.
24. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing the risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
25. Janssens HJEM, Janssen M, van de Lisdonk EH, van Riel PLCM, van Weel C. Use of oral prednisolone or naproxen for the treatment ofgout arthritis: a double-blind, randomised equivalence trial. Lancet 2008;371:1854-60.
26. Janssens HJ, Lucassen PL, Van de Laar FA, Janssen M, Van de Lisdonk EH. Systemic corticosteroids for acute gout. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD005521.pub2]
27. Joosten LAB, Netea MG, Mylona E, Koenders MI, Malireddi RKS, Oosting M, et al. Fatty acids engagement with TLR2 drive IL-1β production via ASC-caspase-1 pathway by urate crystals in gouty arthritis. Arthritis and Rheumatism 2010;62(11):3237-48.
28. Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae SM, Neogi T, et al.2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care and Research 2012;64(10):1447-61.
29. Mikadashi JA, Hochberg MC, Moy EM, White B, Handwerger BS. Single-dose parenteral ACTH in the treatment of acute gouty arthritis: a high benefit to toxicity ratio. Arthritis and Rheumatism 1994;37:S428, 1593.
30. Moi JHY, Sriranganathan MK, Edwards CJ, Buchbinder R. Lifestyle interventions for chronic gout. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD010039.pub2]
31. Neogi T. Gout. New England Journal of Medicine 2011;364:443-52.
32. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
33. Richette P, Bardin T. Gout. Lancet 2010;375:318-28.
34. Richette P, Bardin T. Purine-rich foods: an innocent by stander of gout attacks?. Annals of the Rheumatic Diseases 2012;71(9):1435-6.
35. Schlesinger N. Response to application of ice may help differentiate between gouty arthritis and other inflammatory arthritides. Journal of Clinical Rheumatology 2006;12:275-6.
36. Schlesinger N, Schumacher R, Catton M, Maxwell L. Colchicine for acute gout. Cochrane Database of Systematic Reviews 2006;18(4):CD006190.
37. Schumacher HR. The pathogenesis of gout. Cleveland Clinic Journal of Medicine 2008;75 Suppl 5:S2-4.
38. Schumacher HR, Taylor W, Edwards L, Grainger R, Schlesinger N, Dalbeth N, et al. Outcome domains for studies of acuteand chronic gout and chronic gout. Journal of Rheumatology 2009;36:2342-5.
39. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
40. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
41. Singh JA, Taylor WJ, Simon LS, Khanna PP, Stamp LK, McQueen FM, et al. Patient-reported outcomes in chronic gout: a report from OMERACT 10. Journal of Rheumatology 2011;38:1452-7.
42. Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Current Opinion in Rheumatology 2011;23:192-202.
43. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
44. Wechalekar MD, Vinik O, Schlesinger N, Buchbinder R. Intra-articular glucocorticoids for acute gout. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD009920.pub2]
45. Zhang Y, Neogi T, Chen C, Chaisson C, Hunter DJ, Choi HK. Cherry consumption and decreased risk of recurrent gout. Arthritis and Rheumatism 2012;64(12):4004-11.